Bureau Veritas SA (FRA:4BV)
27.90
-0.02 (-0.07%)
Last updated: Jul 25, 2025
Intra-Cellular Therapies Market Cap
Bureau Veritas has a market cap or net worth of €11.99 billion as of August 1, 2025. Its market cap has decreased by -0.06% in one year.
Market Cap
11.99B
Enterprise Value
13.75B
Revenue
6.62B
Ranking
n/a
PE Ratio
18.24
Stock Price
$27.90
Market Cap Chart
Since October 24, 2007, Bureau Veritas's market cap has increased from 4.12B to 11.99B, an increase of 191.13%. That is a compound annual growth rate of 6.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 11.73B | -10.67% |
Dec 31, 2024 | 13.13B | 26.55% |
Dec 29, 2023 | 10.38B | -6.82% |
Dec 30, 2022 | 11.13B | -15.59% |
Dec 31, 2021 | 13.19B | 35.02% |
Dec 31, 2020 | 9.77B | -5.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 292.08B |
Siemens Aktiengesellschaft | 174.92B |
Deutsche Telekom AG | 153.20B |
Allianz SE | 132.59B |
Siemens Energy AG | 80.60B |
Rheinmetall AG | 79.52B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.53B |
Deutsche Bank Aktiengesellschaft | 55.70B |